slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 27,901-27,930
Pages 1,349
Rows per page 30
Beat
27,901-27,930 of 40,452
24
Includes Kaplan-Meier curves for Overall Survival (A) and Progression-free Survival (B).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
25
Kaplan-Meier survival curve showing PFS. Mentions Tecentriq as brand name for Atezolizumab.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
26
Includes bioluminescence imaging and quantitative bar chart with statistical significance markers (p-values).Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
27
The slide shows four separate bar charts comparing Control, Atezo (Tecentriq), REQORSA, and Combination therapies across four immune cell types.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
28
Clinical trial design slide for a pharmaceutical study.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
29
The chart shows statistical significance (p-values) comparing treatment groups against controls.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
30
The chart shows tumor volume over time (days) for four groups, demonstrating synergistic efficacy of the dual gene therapy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
31
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
32
The slide uses a series of circles to present key metrics, highlighting the global expenditure figure.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
33
Uses an emotional image of a father and child to emphasize the human impact of the disease.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
34
Genprex | Investor Presentation Deck | 58 slidesGenprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
35
Uses a timeline to establish a 'gap' in innovation, followed by three key arguments for why new therapy is needed.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
36
The slide uses a pie chart to illustrate the prevalence split between T1D and T2D.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
37
Includes a scientific diagram illustrating the transition from hyperglycemia (beta-cell deficiency) to euglycemia (restored beta-cell mass) via AAV-mediated gene delivery.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
38
The slide compares AAV8-PM (therapeutic) against AAV8-GFP (control) and an untreated control group.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
39
The slide uses a comparative analogy between mouse lifespan and human lifespan to suggest long-term efficacy.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
40
The slide uses a combination of a process description (left) and experimental data (line chart and bar chart) to validate the therapeutic hypothesis.Genprex | Investor Presentation Deck | 58 slides · Genprex
Pitch deck Investor relations Beat · Visualization1 hit
13
The slide uses a before-and-after comparison framework to justify a shift in business strategy.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
28
The chart highlights a 'pandemic bump' in 2020-2021 and projects a return to positive EBITDA in 2024.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
29
The chart uses a visual arrow to emphasize the projected growth trend from Q3 to Q4.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
30
Grove | Investor Presentation Deck | 35 slidesGrove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
31
Includes detailed financial table and a callout box for liquidity metrics.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
32
Grove | Investor Presentation Deck | 35 slidesGrove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
33
Grove | Investor Presentation Deck | 35 slidesGrove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
34
Standard financial reconciliation table showing adjustments for non-cash and non-recurring items.Grove | Investor Presentation Deck | 35 slides · Grove Collaborative
Pitch deck Investor relations Beat · Financials1 hit
29
The right side uses a concentric circle diagram to illustrate levels of expansion within retail.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Market Size1 hit
30
The chart uses a stacked bar approach to show current reach vs. potential opportunity.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Market Size1 hit
33
The slide features a group photo of the leadership team with specific callouts for the CEO and CFO, and a row of logos representing their past experience.Honest | Investor Presentation Deck | 36 slides · Honest
Pitch deck Investor relations Beat · Team1 hit
18
Hugo Boss | Results Presentation Deck | 20 slidesHugo Boss | Results Presentation Deck | 20 slides · Hugo Boss
Conference presentation Investor relations Beat · Visualization1 hit
19
Hugo Boss | Results Presentation Deck | 20 slidesHugo Boss | Results Presentation Deck | 20 slides · Hugo Boss
Conference presentation Investor relations Beat · Visualization1 hit